IMPG2 and retinitis pigmentosa: For example, Mayerl et al. [4] reported that unlike interphotoreceptor matrix proteoglycan 2 (IMPG2) knockout mice, retinal organoids generated using retinitis pigmentosa patient-derived iPSCs displayed typical clinical disease phenotypes, including photoreceptor outer segment loss, when IMPG2 mutations were inserted.